For instance, four genes (BUB1B, BUB1, TTK, and CCNB1) that are pronouncedly upregulated in ovarian cancer and indicate dismal prognosis were disclosed through bioinformatic methods, and they can be used as potential therapeutic targets for patients with ovarian cancer (Feng et al., 2019). This evidence concerns the gene BUB1B and ovarian cancer.